-
Product Insights
Macular Edema Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Macular Edema Global Clinical Trials Review, H2, 2017" provides an overview of Macular Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Macular Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
EpiCast Report: Glaucoma – Epidemiology Forecast to 2026
Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’s optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people. Glaucoma is generally categorized as open-angle glaucoma (OAG), angle-closure glaucoma (ACG), or secondary glaucoma (SG), though other less common types exist. OAG and ACG can be classified as primary (primary open-angle glaucoma [POAG] or primary angle-closure glaucoma [PACG], respectively) or SG, depending on...
-
Product Insights
Hypotrichosis Of Eyelashes Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hypotrichosis Of Eyelashes Global Clinical Trials Review, H2, 2017" provides an overview of Hypotrichosis Of Eyelashes clinical trials scenario. This report provides top line data relating to the clinical trials on Hypotrichosis Of Eyelashes. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Intermediate Uveitis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Intermediate Uveitis Global Clinical Trials Review, H2, 2017" provides an overview of Intermediate Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Intermediate Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Juvenile Macular Degeneration (Stargardt Disease) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Juvenile Macular Degeneration (Stargardt Disease) Global Clinical Trials Review, H2, 2017" provides an overview of Juvenile Macular Degeneration (Stargardt Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Juvenile Macular Degeneration (Stargardt Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Myopia Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, H1, 2018" provides an overview of Myopia clinical trials scenario. This report provides top line data relating to the clinical trials on Myopia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Neovascular Glaucoma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neovascular Glaucoma Global Clinical Trials Review, H1, 2018" provides an overview of Neovascular Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Neovascular Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Normal-Tension Glaucoma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Normal-Tension Glaucoma Global Clinical Trials Review, H1, 2018" provides an overview of Normal-Tension Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Normal-Tension Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Blepharitis Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Blepharitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Avitaminosis (Hypovitaminosis) Clinical trials scenario. This report provides top line data relating to the clinical trials on Avitaminosis (Hypovitaminosis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Conjunctivitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Conjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...